Preliminary trial results further highlight substantial improvements in cardiovascular markers among patients treated with Retatrutide, including reduced systemic inflammation markers (like CRP), lowered lipid profiles, and enhanced cardiac efficiency
An ongoing randomized, open-label, phase 3 trial sponsored by the Centre Hospitalier Universitaire Dijon (Dijon, France) is already investigating the efficacy of semaglutide (administered as add-on to insulin treatment for 26 weeks) in improving glucose control among adult patients with double diabetes [ClinicalTrials.gov ID: NCT05305794] [147]
It helps: Regenerate vitamins C & E
If Canada is serious about building a resilient and competitive food system, we need to start paying closer attention, not just to what food costs, but to how much of it people will actually want to consume in the future
The difficult weeks seem distant